News

Filter

Current filters:

Arcapta

US FDA delays decision on Novartis COPD drug candidate indacaterol

24-03-2011

The US Food and Drug Administration has extended the regulatory review period for Swiss drug major Novartis’…

ArcaptaindacaterolNorth AmericaNovartisPharmaceuticalRegulationRespiratory and Pulmonary

Novartis COPD drug indacaterol gets mixed message from FDA advisory committee

09-03-2011

The US Food and Drug Administration should approve Swiss drug major Novartis’ (NOVN: VX) QAB149…

ArcaptaindacaterolNorth AmericaNovartisOnbrezPharmaceuticalRegulationRespiratory and Pulmonary

COMPANY SPOTLIGHT

Menarini

Back to top